Trump#39;s #39;Buy American#39; order for essential drugs may have limited impact on Indian pharma companies

India#39;s contribution to the $65-$70 billion US generics market is only about 10 percent, says pharma trade body Pharmexcil, and the cost of production here is 40 percent lower than in North America and Europe

from Moneycontrol Business News https://ift.tt/2PwAAu3